Novartis AG
Methods for treating liver disorders using FXR agonists
Last updated:
Abstract:
The invention provides methods for modulating the activity of farnesoid X receptors (FXRs) using specific FXR agonists, in particular for treating or preventing liver diseases.
Status:
Grant
Type:
Utility
Filling date:
20 Feb 2017
Issue date:
31 May 2022